Harrow HROW
NASDAQ HROW
$28.43 +0.36 (+1.28%)
As of: Oct 21, 2026 · 11:34 AM EDT

Harrow (HROW) Convertible Debt (2010 - 2016)

Updated

Harrow (HROW) recorded Convertible Debt of $914,000 in Q3 2016, up 20.6% from the prior quarter.

Analysis

Harrow (HROW) Convertible Debt (2010 - 2016) Analysis & Trends

At the end of FY2011, Harrow reported Convertible Debt of $1.3 million, up 23.2% from FY2010.

  • Across earlier years, Convertible Debt came in at $1.06 million in FY2010.
  • The Q3 2016 figure is the highest quarterly Convertible Debt since Q4 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn
10 Harrow 1.06 Bn 736.12 Mn 50.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 914,000.00
Jun 30, 2016 758,000.00
Dec 31, 2011 1.30 Mn
Dec 31, 2010 1.06 Mn
API Access

Harrow Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=HROW&period=max&api_key=YOUR_API_KEY